Abbott’s Panbio Rapid Antigen Test Receives CE Mark for Mass COVID-19 Screening
Shots: The approval is based on the study assessing Ruzurgi vs PBO in 32 adult patients while patients taking Ruzurgi for at least three months prior to entering the study The study measured effectiveness of a patient to rise from a chair, walk three meters & return to the chair for three consecutive laps without […]Read More
